AVTX: Avalo Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 11.53
Enterprise Value ($M) -87.19
Book Value ($M) -101.08
Book Value / Share -97.75
Price / Book -0.11
NCAV ($M) -113.60
NCAV / Share -109.85
Price / NCAV -0.10

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -3.94
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.52
Current Ratio 0.52

Balance Sheet (mrq) ($M)
Current Assets 111.21
Assets 123.73
Liabilities 224.81
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.92
Operating Income -23.44
Net Income -31.54
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -30.68
Cash from Investing -0.13
Cash from Financing 25.04

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
05-13 13G Allostery Investments LP 7.60
04-23 13G Emerald Bioventures, LLC 5.60
04-05 13G Deep Track Capital, LP 9.99
02-14 13G/A Venrock Healthcare Capital Partners III, L.P. 0.00 -100.00
02-14 13G/A Nantahala Capital Management, LLC 4.90 -93.57
02-14 13G/A Great Point Partners Llc 0.26
02-14 13G/A Point72 Asset Management, L.P. 0.30 -99.96
06-29 13G/A Caissa Capital Management ltd. 0.00 -100.00
06-28 13D/A Armistice Capital, Llc 4.99 -86.97

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-24 6,119 11,639 52.57
2024-05-23 9,286 6,036 153.84
2024-05-22 2,509 1,468 170.91
2024-05-21 4,181 3,591 116.43
2024-05-20 17,426 7,687 226.69

(click for more detail)

Similar Companies
ATNF – 180 Life Sciences Corp. ATOS – Atossa Therapeutics, Inc.
ATXI – Avenue Therapeutics, Inc. AWH – Aspira Women's Health Inc.
AYTU – Aytu BioPharma, Inc.


Financial data and stock pages provided by
Fintel.io